NOVAVAX INC

NVAX

Form 4 • Statement of Changes in Beneficial Ownership

SEC Accession Number: 0001104659-26-023726
Filing date: Mar 5, 2026
Earliest execution date: Mar 3, 2026
Reporting Owners: Jacobs John C (CEO)

Summary

Type

Sell

Net shares

-69,288

% of shares

-23.49%

Amount (USD)

$657,543

Insider confidence score

40.0 out of 100

Positive

  • Tax withholding obligation

Negative

  • Large tax withholding sell (≥1% of shares)
  • Large sell amount ($250K+)

Stock transactions

Transaction 1

Security

Common Stock

Action

Exercise

Date

2026-03-03

Code

M

Net shares

+150,167.0

Acquired/Disposed

Acquired

Shares Owned Before

113,963.0

Shares Owned After

264,130.0

Transaction 2

Security

Common Stock

Action

Tax_withhold

Date

2026-03-03

Code

F

Net shares

-69,288.0

Price per Share

$9.49

Amount (USD)

$657,543.12

Acquired/Disposed

Disposed

Shares Owned Before

294,968.0

Shares Owned After

225,680.0

Derivative Transactions

Transaction 1

Security

Restricted Stock Units

Action

Exercise

Date

2026-03-03

Code

M

Net shares

-150,167.0

Acquired/Disposed

Disposed

Shares Owned Before

450,500.0

Shares Owned After

300,333.0

Filing's footnotes

1. Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting.

2. One-third (1/3) of the RSUs subject to this grant under the Novavax, Inc. Amended and Restated 2015 Stock Incentive Plan, as amended, (the "Plan") vest on each of the first three (3) anniversaries of March 3, 2025, in each case subject to continued employment through such vesting date.

This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.